Sara Bombace

Dr. Sara Bombace

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Circulation
Verified
Journal Article
Closed access
MCMarco Cremonesi
Marco Cremonesi
AFArianna Felicetta
Arianna Felicetta
FCFrancesco Cannata
Francesco Cannata
SSSimone Serio
Simone Serio
JBJasper Van Beek
Jasper Van Beek
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli

17 June 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SBSara Bombace
Sara Bombace
MMMaria Chiara Meucci
Maria Chiara Meucci
FFFederico Fortuni
Federico Fortuni
Federica IlardiFederica Ilardi
Federica Ilardi
RMRachele Manzo
Rachele Manzo
ASAnna Sannino
Anna Sannino
Aortic stenosis (AS) can often coexist with other valvular diseases or be combined with aortic regurgitation (AR), leading to unique pathophysiological conditions. The combination of affected valves can vary widely, resulting in a lack of standardized diagnostic or therapeutic approaches. Echocardiography is crucial in assessing patients with valvular heart disease (VHD), but careful consideration of the hemodynamic interactions between combined valvular defects is necessary. This is important as it may affect the reliability of commonly used echocardiographic parameters, making the diagnosis challenging. Therefore, a multimodality imaging approach, including computed tomography or cardiac magnetic resonance, is often not just beneficial but crucial. It represents the future of diagnostics in this intricate field due to its unprecedented capacity to quantify and comprehend valvular pathology. The absence of definitive data and guidelines for the therapeutic management of AS in the context of multiple valve lesions makes this condition particularly challenging. As a result, an individualized, case-by-case approach is necessary, guided primarily by the recommendations for the predominant valve lesion. This review aims to summarize the pathophysiology of AS in the context of multiple and mixed valve disease, with a focus on the hemodynamic implications, diagnostic challenges, and therapeutic options.

Verified
Journal Article
Open access
PDF file
Marco RanucciMarco Ranucci
Marco Ranucci
GPGianfranco Parati
Gianfranco Parati
UDUmberto Di Dedda
Umberto Di Dedda
MBMaurizio Bussotti
Maurizio Bussotti
EAEustachio Agricola
Eustachio Agricola
MRMaria Teresa La Rovere
Maria Teresa La Rovere
Background: Hospital mortality and admission to the Intensive Care Unit (ICU) are markers of disease severity in COVID-19 patients. Cardiovascular co-morbidities are one of the main determinants of negative outcomes. In this study we investigated the impact of cardiovascular co-morbidities on mortality and admission to the ICU in first-wave COVID-19 patients. Methods: A multicenter, retrospective, cohort study. A total of 1077 patients were analyzed for mortality and ICU admission. Cardiovascular risk factors were explored as determinants of the outcomes after correction for other confounders. Results: In the multivariable model, after correction for age, only a history of heart failure remained independently associated (p = 0.0013) with mortality (hazard ratio 2.22, 95% confidence interval 1.37 to 3.62). Age showed a mortality risk increase of 8% per year (hazard ratio 1.08, 95% confidence interval 1.05 to 1.10, p = 0.001). The transition from ward to the ICU had, as a single determinant, the age, but in a reversed fashion (hazard ratio 0.96, 95% confidence interval 0.94 to 0.98, p = 0.0002). Conclusions: Once adjusted for the main determinant of mortality (age) heart failure only remained independently associated with mortality. Admission to the ICU was less likely for elderly patients. This may reflect the catastrophic impact of the first wave of COVID-19 pandemic in terms of ICU bed availability in Lombardy, leading to a selection process for ICU admission.

14 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SBSara Bombace
Sara Bombace
IMIlaria My
Ilaria My
MFMarco Francone
Marco Francone
LMLorenzo Monti
Lorenzo Monti
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that presents with cardiac hypertrophy. HCM phenocopies are clinical conditions that are phenotypically undistinguishable from HCM, but with a different underlying etiology. Cardiac tumors are rare entities that can sometimes mimic HCM in their echocardiographic appearance, thus representing an example of HCM phenocopy. At present, only case reports of tumoral HCM phenocopies can be found in literature. In this systematic review, we analyzed all the published cases in which a cardiac tumor mimicked HCM to the point of misleading the diagnosis, providing a structured overview of the currently available evidence on this topic.